Discover
EBS
Emergent BioSolutions Inc.
8.28
200 x undefined
400 x undefined
bid
ask
-
0.10
1.19%
300 @ 05:51 AM
8.31 +0.03 (0.36%)
| Ytd | -33.01% | |
| 1y | 25.45% |
8.27
day range
8.63
5.62
52 week range
14.06
| Open | 8.31 | Prev Close | 8.38 | Low | 8.27 | High | 8.63 | Mkt Cap | 427.22M |
| Vol | 430.98K | Avg Vol | 810.94K | EPS | -0.19 | P/E | N/A | Forward P/E | 2.73 |
| Beta | 1.57 | Short Ratio | 4.54 | Inst. Own | 60.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 8.37 | 200-d Avg | 9.72 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 156.10M | ||
| Revenues (USD) | 156.10M | ||
| Cost of Revenue | 72.00M | ||
| Gross Profit | 84.10M | ||
| Operating Expenses | 73.60M | ||
| Research and Development Expense | 10.50M | ||
| Selling, General and Administrative Expense | 46.60M | ||
| Operating Income | 10.50M | ||
| Interest Expense | 11.00M | ||
| Income Tax Expense | 6.60M | ||
| Net Income | 6.80M | ||
| Net Income Common Stock | 6.80M | ||
| Net Income Common Stock (USD) | 6.80M | ||
| Consolidated Income | 6.80M | ||
| Earnings per Basic Share | 0.13 | ||
| Earnings per Basic Share (USD) | 0.13 | ||
| Earnings per Diluted Share | 0.07 | ||
| Earning Before Interest & Taxes (EBIT) | 24.40M | ||
| Earning Before Interest & Taxes (USD) | 24.40M | ||
| Weighted Average Shares | 51.90M | ||
| Weighted Average Shares Diluted | 56.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 161.50M | ||
| Cash and Equivalents (USD) | 161.50M | ||
| Trade and Non-Trade Receivables | 121.60M | ||
| Current Assets | 637.60M | ||
| Property, Plant & Equipment Net | 199.40M | ||
| Total Assets | 1.32B | ||
| Total Debt | 573.60M | ||
| Current Liabilities | 148.70M | ||
| Debt Non-Current | 573.60M | ||
| Total Liabilities | 797.30M | ||
| Accumulated Retained Earnings (Deficit) | -153.00M | ||
| Accumulated Other Comprehensive Income | -6.90M | ||
| Shareholders Equity | 523.10M | ||
| Shareholders Equity (USD) | 523.10M | ||
| Assets Non-Current | 682.80M | ||
| Total Debt (USD) | 573.60M | ||
| Deferred Revenue | 12.20M | ||
| Goodwill and Intangible Assets | 470.40M | ||
| Inventory | 327.60M | ||
| Liabilities Non-Current | 648.60M | ||
| Trade and Non-Trade Payables | 39.50M | ||
| Tax Liabilities | 40.50M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.50M | ||
| Net Cash Flow from Financing | -11.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -47.60M | ||
| Capital Expenditure | -2.40M | ||
| Issuance (Purchase) of Equity Shares | -8.60M | ||
| Net Cash Flow from Investing | -2.40M | ||
| Net Cash Flow from Operations | -33.80M | ||
| Share Based Compensation | 1.90M | ||